Lung Clearance Index Improves in People with Cystic Fibrosis not Achieving a Clinical Important Difference in Forced Expiratory Volume in One Second After Elexacaftor/Tezacaftor/Ivacaftor Therapy
Valeria Daccò, Andrea Gramegna, Chiara Rosazza, Alessandra Mariani, Arianna Biffi, Chiara Lanfranchi, Laura Zazzeron, Federica Bellante, Francesco Blasi, Gianfranco Alicandro
Topics & Concepts
Minimal clinically important differenceMedicineSpirometryIvacaftorCystic fibrosisPhysical therapyPopulationLung volumesLung functionObservational studyInternal medicineLungAsthmaRandomized controlled trialCystic fibrosis transmembrane conductance regulatorEnvironmental healthCystic Fibrosis Research AdvancesTracheal and airway disordersNeonatal Respiratory Health Research